European Urology

Assets

Create Platinum Slide Series

6 slide in article Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report


Viewing slides 1-6 of 6

  • S0302-2838(08)01109-3.title drag remove slide sort drag into slide Title Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report

    Apostolos Apostolidis a, Prokar Dasgupta ...
    Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and ...
    Zoom
  • S0302-2838(08)01109-3.introduction drag remove slide sort drag into slide Introduction • Due to the increasing number of potential indications for the use of Botulinum neurotoxins(BoNTs)in urological and pelvic floor disorders, the wide variety of injected doses, injection ... • Due to the increasing number of potential indications for the use of Botulinum ... Zoom
  • 4447 drag remove slide sort drag into slide gr1 Proposed mechanism of action of botulinum toxin type A (BoNTA) injected into ... Zoom read this article »
  • S0302-2838(08)01109-3.materials_and_methods drag remove slide sort drag into slide Materials and methods • The quality of evidence from fully published English language literature in the PubMed and EMBASE databases until January 2008 was assessed using the EAU levels of evidence (LoE)

    • ...
    • The quality of evidence from fully published English language literature in the PubMed and ...
    Zoom
  • S0302-2838(08)01109-3.results drag remove slide sort drag into slide Results • The use of BoNT/A is recommended (Grade A) in the treatment of intractable symptoms of neurogenic and idiopathic detrusor overactivity (NDO/IDO) in adults willing to use clean intermittent ... • The use of BoNT/A is recommended (Grade A) in the treatment of intractable symptoms of ... Zoom
  • S0302-2838(08)01109-3.conclusion drag remove slide sort drag into slide Conclusion • The use of BoNT/A is recommended in the treatment of intractable symptoms of NDO and -with caution- IDO in patients willing to use CIC

    • Heterogeneous study designs and lack of large, ...
    • The use of BoNT/A is recommended in the treatment of intractable symptoms of NDO and -with ...
    Zoom

Viewing slides 1-6 of 6

PLATINUM SLIDE SERIES

Due to the standard formatting procedure, figures and legends may be difficult to view when downloaded. Users are asked to manipulate the text font and figure size manually in order to optimize visualization. Please contact the Editorial Office if you need assistance.

idle

Drop your slides here

Create Powerpoint

Top 10 cited